Picture of Lifevantage logo

LFVN — Lifevantage Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Annual income statement for Lifevantage, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K8-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalPreliminary
Revenue
Total Revenue206213200229183
Cost of Revenue
Gross Profit168170159184—
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses201209196216—
Operating Profit5.374.264.3312.2—
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Other Net Non Operating Costs
Net Income Before Taxes4.6944.3512.26.07
Provision for Income Taxes
Net Income After Taxes3.122.542.949.8—
Net Income Before Extraordinary Items
Net Income3.122.542.949.8—
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income3.122.542.949.8—
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.3510.2220.2260.755—
Dividends per Share
Special Dividends per Share